JATT Acquisition Corp
Status: Deal Closed
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $138.00M |
|---|---|
| IPO Date | Jul 14, 2021 |
| CEO | Dr. Someit Sidhu |
| Left Lead | Raymond James |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 18 + 3 |
| IPO Sector |
Healthcare
Businesses primarily operating in the life sciences sector |
| IPO Geography | Global |
| Target Company | Zura Bio |
| Deal Announced | Jun 17, 2022 |
| Deal Size, $M | $214.80M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Mar 16, 2023 |
| Amendment Vote | Jan 12, 2023 |
| Closing Date | Mar 21, 2023 |
Formerly JATT
ZURA
ZURAW
| Price | $3.61 |
|---|---|
| Last closing price | $3.69 |
| H/L, today | $3.25 / $3.88 |
| H/L, 52-week | $4.49 / $37.55 |
| Volume, today | 240,674 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | $0.35 |
|---|---|
| Last closing price | $0.31 |
| High/low price, today | $0.29 / $0.35 |
| High/low price, 52-week | $0.12 / $0.69 |
| Volume, today | 12,453 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on JATT Acquisition Corp:
- Structure and cap table
- 6 directors & officers
- 36 filings and events
- 1 underwriters
- 3 deal advisors
- 5 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Dr. Someit Sidhu | 31 | Chairman and Chief Executive Officer |
| Tauhid Ali | 53 | Chief Operating Officer and Director |
| Verender S. Badial | 48 | Chief Financial Officer |
| Arnout Ploos van Amstel | 57 | Director |
| Javier Cote-Sierra | 58 | Director |
| Graeme Sloan | 57 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Raymond James | BR | 12,000,000 | units |
| 12,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 36 filings.